[1]
2021. Ex-vivo and in-vivo evaluation of nanostructured lipid carrier loaded with gemcitabine and paclitaxel in A549 lung cell for management of resistant cancers. International Journal of Pharmaceutical Sciences and Drug Research. 13, 4 (Jul. 2021), 410–417. DOI:https://doi.org/10.25004/IJPSDR.2021.130407.